Many firsts in 2020, and much to leave behind! But one “first” is the ISBT 128 labeling standard for cells collected for further manufacture. While voluntary for manufacturers, I would strongly encourage everyone to request of manufacturers that they comply with ISBT 128 labeling standards as they will contribute to the safety of our patients and to the efficiency of our laboratories, collection groups, and electronic records. If we all speak with the same voice perhaps headway will be made.
Our virtual accreditation task force continues to refine the process for virtual inspections, which we plan to begin soon. As other accrediting bodies perform virtual inspections and we all have more experience with virtual meetings, I think the overall process will not be that different. But we all look forward to the day we can do in-person inspections again, as nothing replaces the direct interactions and the ability to make new friends and acquaintances.
As we face the biggest peak yet of COVID-19 infections and the pressure at work increases, the importance of taking care of yourself away from work increases, too. Please stay safe—there is a light at the end of the tunnel – not an oncoming train, but vaccines with a level of efficacy that is truly remarkable. Happy Holidays with your friends and families!